Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the 340b Transparency topic

No spam. Unsubscribe anytime.

Senate panel advances 340B transparency bill after amendment narrows conflicts with existing law

2710244 · March 19, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Senate Health & Human Services Committee approved an amendment that strips parts of Senate Bill 124 found to conflict with federal 340B program rules, then sent the bill as amended to the Committee of the Whole with a favorable recommendation.

Senate Health and Human Services on an amended vote advanced Senate Bill 124, a measure aimed at increasing transparency around entities’ use of funds generated under the federal 340B drug-pricing program.

The committee adopted a compromise amendment, labeled L‑8, that removes provisions committee members said conflict with prior committee legislation and the structure of federal 340B law. After adopting L‑8, the committee voted to send SB 124, as amended, to the Committee of the Whole with a favorable recommendation.

The bill’s sponsors and amendment authors said the measure’s remaining provisions would retain reporting and enforcement sections while removing the subsections that most directly conflicted with earlier committee action and federal program rules. Sponsor remarks emphasized the effort to preserve patient‑centric transparency while avoiding provisions that could interfere with how 340B operates under federal law.

Senator Mike Weisman, who advocated for narrowing the bill, described L‑8 as removing the conflicting material from pages 3–4 and leaving intact reporting requirements and enforcement language later in the text. He said the change was intended to reduce direct conflict with earlier committee-passed legislation and to leave in place reporting and certain restrictions on how 340B proceeds are used (for example, limits on using proceeds for lobbying or advertising), while enabling continued debate at second reading.

Senator Gonzalez and other members thanked sponsors for negotiating and for meeting with patients and stakeholders who testified at the hearing. Committee members emphasized multiple goals: preserving rural and safety‑net hospitals from unintended harm, protecting patient access, and improving transparency about how 340B proceeds are spent.

The amendment phase produced a recorded committee roll call on L‑8; the amendment passed on a recorded vote. After discussion closed, the committee approved SB 124 as amended by a recorded vote and sent it forward to the Committee of the Whole with a favorable recommendation.

The bill retains a request-for‑information provision directing the Joint Budget Committee and the state department to collect data on any losses to the state medical assistance program related to nonprofit hospital purchases and 340B practices, according to sponsor remarks. Sponsors said that provision (identified in the bill as Section 307) is intended to provide the state better data for budgeting decisions.

Committee members stressed the work is not finished: several senators said they expect continued conversations with sponsors and stakeholders to harmonize elements of SB 124 with other pending legislation affecting 340B recipients.

Votes at a glance: L‑8 amendment — passed (recorded roll call, amendment passed by committee). SB 124 as amended — approved and referred to the Committee of the Whole (committee recorded vote: tally reported as 6 yes, 3 no).